sorafenib has been researched along with emodin in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (emodin) | Trials (emodin) | Recent Studies (post-2010) (emodin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,792 | 3 | 1,102 |
| Protein | Taxonomy | sorafenib (IC50) | emodin (IC50) |
|---|---|---|---|
| Chain A, PROTEIN KINASE CK2, ALPHA SUBUNIT | Zea mays | 1 | |
| Protein tyrosine phosphatase type IVA 3 | Homo sapiens (human) | 3.5 | |
| Estrogen receptor | Homo sapiens (human) | 2.7 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 3.73 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 1.22 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 2.5 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.69 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 1.04 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 0.24 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.32 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.24 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 1.22 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 0.8667 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 1.0112 | |
| Estrogen receptor beta | Homo sapiens (human) | 5.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kan, SY; Kang, H; Kim, BM; Kim, GH; Kim, JH; Kim, YS; Lee, YM; Lim, JH; Oh, TI; Shin, DH; Yim, WJ | 1 |
1 other study(ies) available for sorafenib and emodin
| Article | Year |
|---|---|
Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Synergism; Emodin; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Sterol Regulatory Element Binding Protein 2; Xenograft Model Antitumor Assays | 2018 |